MAGE‐A3 has been described as a mediator of extracellular matrix protein function which promotes tumor cell migration 26 and it is therefore possible that expression of MAGE‐A3 is activated during NSGCTT metastasis and that a specific immune response is subsequently induced at the secondary tumor site. The gene discussed is MAGEA3; the disease is neoplasm.